Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Goldsmith, Jory A."" wg kryterium: Autor


Wyświetlanie 1-10 z 10
Tytuł :
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.
Autorzy :
Jones BE; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA. .
Brown-Augsburger PL; Eli Lilly and Company, Indianapolis, IN 46225, USA.
Corbett KS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Westendorf K; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Davies J; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.
Cujec TP; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.
Wiethoff CM; Eli Lilly and Company, Indianapolis, IN 46225, USA.
Blackbourne JL; Eli Lilly and Company, Indianapolis, IN 46225, USA.
Heinz BA; Eli Lilly and Company, Indianapolis, IN 46225, USA.
Foster D; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.
Higgs RE; Eli Lilly and Company, Indianapolis, IN 46225, USA.
Balasubramaniam D; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.
Wang L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Zhang Y; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Yang ES; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Bidshahri R; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Kraft L; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Hwang Y; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Žentelis S; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Jepson KR; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Goya R; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Smith MA; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Collins DW; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Hinshaw SJ; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Tycho SA; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Pellacani D; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Xiang P; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Muthuraman K; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Sobhanifar S; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Piper MH; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.
Triana FJ; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.
Hendle J; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.
Pustilnik A; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, CA 92121, USA.
Adams AC; Eli Lilly and Company, Indianapolis, IN 46225, USA.
Berens SJ; Eli Lilly and Company, Indianapolis, IN 46225, USA.
Baric RS; University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Martinez DR; University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Cross RW; Galveston National Laboratory and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Geisbert TW; Galveston National Laboratory and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Borisevich V; Galveston National Laboratory and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Abiona O; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Belli HM; Department of Population Health, Division of Biostatistics, New York University Grossman School of Medicine, New York, NY 10016, USA.
de Vries M; Department of Microbiology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Mohamed A; Department of Microbiology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Dittmann M; Department of Microbiology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Samanovic MI; NYU Langone Vaccine Center, Department of Medicine, Division of Infectious Diseases and Immunology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Mulligan MJ; NYU Langone Vaccine Center, Department of Medicine, Division of Infectious Diseases and Immunology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Goldsmith JA; Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712, USA.
Hsieh CL; Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712, USA.
Johnson NV; Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712, USA.
Wrapp D; Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712, USA.
McLellan JS; Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712, USA.
Barnhart BC; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Hansen CL; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada.
Falconer E; AbCellera Biologics Inc., Vancouver, BC V5Y0A1, Canada. .
Pokaż więcej
Źródło :
Science translational medicine [Sci Transl Med] 2021 May 12; Vol. 13 (593). Date of Electronic Publication: 2021 Apr 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Czasopismo naukowe
Tytuł :
Shielding and Beyond: The Roles of Glycans in SARS-CoV-2 Spike Protein.
Autorzy :
Casalino L; Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.
Gaieb Z; Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.
Goldsmith JA; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Hjorth CK; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Dommer AC; Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.
Harbison AM; Department of Chemistry and Hamilton Institute, Maynooth University, Dublin, Ireland.
Fogarty CA; Department of Chemistry and Hamilton Institute, Maynooth University, Dublin, Ireland.
Barros EP; Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.
Taylor BC; Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.; Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA, 92093, USA.
McLellan JS; Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.; Department of Chemistry and Hamilton Institute, Maynooth University, Dublin, Ireland.; Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA, 92093, USA.
Fadda E; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.; Department of Chemistry and Hamilton Institute, Maynooth University, Dublin, Ireland.
Amaro RE; Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.; Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA, 92093, USA.
Pokaż więcej
Źródło :
BioRxiv : the preprint server for biology [bioRxiv] 2020 Jun 11. Date of Electronic Publication: 2020 Jun 11.
Typ publikacji :
Preprint
Tytuł :
Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes.
Autorzy :
Hsieh CL; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Goldsmith JA; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Schaub JM; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
DiVenere AM; Department of Chemical Engineering, University of Texas at Austin, Austin, Texas 78712.
Kuo HC; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Javanmardi K; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Le KC; Department of Chemical Engineering, University of Texas at Austin, Austin, Texas 78712.
Wrapp D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Lee AG; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Liu Y; Department of Chemical Engineering, University of Texas at Austin, Austin, Texas 78712.
Chou CW; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Byrne PO; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Hjorth CK; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Johnson NV; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Ludes-Meyers J; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Nguyen AW; Department of Chemical Engineering, University of Texas at Austin, Austin, Texas 78712.
Park J; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Wang N; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Amengor D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Maynard JA; Department of Chemical Engineering, University of Texas at Austin, Austin, Texas 78712.
Finkelstein IJ; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.; Center for Systems and Synthetic Biology, University of Texas at Austin, Austin, Texas 78712.
McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712.
Pokaż więcej
Źródło :
BioRxiv : the preprint server for biology [bioRxiv] 2020 May 30. Date of Electronic Publication: 2020 May 30.
Typ publikacji :
Preprint
Tytuł :
Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation.
Autorzy :
Wrapp D; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Wang N; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Corbett KS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Goldsmith JA; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Hsieh CL; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Abiona O; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Pokaż więcej
Źródło :
BioRxiv : the preprint server for biology [bioRxiv] 2020 Feb 15. Date of Electronic Publication: 2020 Feb 15.
Typ publikacji :
Preprint
    Wyświetlanie 1-10 z 10

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies